Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

201 - 220 of 376 works

2019

Journal Article

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

Wagner, Elias, Wobrock, Thomas, Kunze, Birgit, Langguth, Berthold, Landgrebe, Michael, Eichhammer, Peter, Frank, Elmar, Cordes, Joachim, Wölwer, Wolfgang, Winterer, Georg, Gaebel, Wolfgang, Hajak, Göran, Ohmann, Christian, Verde, Pablo E., Rietschel, Marcella, Ahmed, Raees, Honer, William G., Siskind, Dan, Malchow, Berend, Strube, Wolfgang, Schneider-Axmann, Thomas, Falkai, Peter and Hasan, Alkomiet (2019). Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. Schizophrenia Research, 208, 370-376. doi: 10.1016/j.schres.2019.01.021

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine

2019

Journal Article

We snooze, they lose: where is the conversation about obstructive sleep apnoea in early psychosis?

Lane, Abigail R, Foley, Sharon and Siskind, Dan (2019). We snooze, they lose: where is the conversation about obstructive sleep apnoea in early psychosis?. Australasian Psychiatry, 27 (3), 314-314. doi: 10.1177/1039856219828203

We snooze, they lose: where is the conversation about obstructive sleep apnoea in early psychosis?

2019

Journal Article

The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study

Siskind, D., Reddel, T., MacCabe, J. H. and Kisely, S. (2019). The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study. Psychopharmacology, 236 (6), 1931-1935. doi: 10.1007/s00213-019-5179-6

The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study

2019

Journal Article

A place to call home: hearing the perspectives of people living with homelessness and mental illness through service evaluation

O'Donovan, Julie, Russell, Karen, Kuipers, Pim, Siskind, Dan and Elphinston, Rachel A. (2019). A place to call home: hearing the perspectives of people living with homelessness and mental illness through service evaluation. Community Mental Health Journal, 55 (7), 1218-1225. doi: 10.1007/s10597-019-00406-8

A place to call home: hearing the perspectives of people living with homelessness and mental illness through service evaluation

2019

Journal Article

Clozapine augmentation strategies – a systematic meta-review of available evidence. Treatment options for clozapine resistance

Wagner, Elias, Löhrs, Lisa, Siskind, Dan, Honer, William G., Falkai, Peter and Hasan, Alkomiet (2019). Clozapine augmentation strategies – a systematic meta-review of available evidence. Treatment options for clozapine resistance. Journal of Psychopharmacology, 33 (4), 423-435. doi: 10.1177/0269881118822171

Clozapine augmentation strategies – a systematic meta-review of available evidence. Treatment options for clozapine resistance

2019

Journal Article

An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia

McArdle, P. A., De Mel, V., DeMonte, V., Winckel, K., Gore-Jones, V., Foley, S., Korman, N., Parker, S., Dark, F. and Siskind, D. (2019). An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. Schizophrenia Research, 206, 450-451. doi: 10.1016/j.schres.2018.11.030

An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia

2019

Journal Article

A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia

Myles, Nicholas, Myles, Hannah, Xia, Shelley, Large, Matthew, Bird, Robert, Galletly, Cherrie, Kisely, Steve and Siskind, Dan (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian and New Zealand Journal of Psychiatry, 53 (5), 403-412. doi: 10.1177/0004867419833166

A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia

2019

Journal Article

Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases

Warren, Nicola, Grote, Vanessa, O’Gorman, Cullen and Siskind, Dan (2019). Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases. Brain Stimulation, 12 (2), 329-334. doi: 10.1016/j.brs.2018.11.016

Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases

2019

Journal Article

Treatment strategies for Clozapine-induced sialorrhea: a systematic review and meta-analysis

Chen, Shih-Yu, Ravindran, Gopi, Zhang, Qichen, Kisely, Steve and Siskind, Dan (2019). Treatment strategies for Clozapine-induced sialorrhea: a systematic review and meta-analysis. CNS Drugs, 33 (3), 225-238. doi: 10.1007/s40263-019-00612-8

Treatment strategies for Clozapine-induced sialorrhea: a systematic review and meta-analysis

2019

Journal Article

A systematic review of service models and evidence relating to the clinically operated community-based residential mental health rehabilitation for adults with severe and persisting mental illness in Australia

Parker, Stephen, Hopkins, Gordon, Siskind, Dan, Harris, Meredith, McKeon, Gemma, Dark, Frances and Whiteford, Harvey (2019). A systematic review of service models and evidence relating to the clinically operated community-based residential mental health rehabilitation for adults with severe and persisting mental illness in Australia. BMC Psychiatry, 19 (1) 55, 55. doi: 10.1186/s12888-019-2019-5

A systematic review of service models and evidence relating to the clinically operated community-based residential mental health rehabilitation for adults with severe and persisting mental illness in Australia

2019

Journal Article

Does the frequency of administration of long acting injectable antipsychotics impact psychiatric outcomes and adverse effects: a systematic review and meta-analysis

Ting, Erich, Kamalvand, Sebnem, Shang, Dongxu, Siskind, Dan and Kisely, Steve (2019). Does the frequency of administration of long acting injectable antipsychotics impact psychiatric outcomes and adverse effects: a systematic review and meta-analysis. Journal of Psychiatric Research, 109, 193-201. doi: 10.1016/j.jpsychires.2018.12.004

Does the frequency of administration of long acting injectable antipsychotics impact psychiatric outcomes and adverse effects: a systematic review and meta-analysis

2019

Journal Article

The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials

Vancampfort, Davy, Firth, Joseph, Correll, Christoph U., Solmi, Marco, Siskind, Dan, De Hert, Marc, Carney, Rebekah, Koyanagi, Ai, Carvalho, André F., Gaughran, Fiona and Stubbs, Brendon (2019). The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry, 18 (1), 53-66. doi: 10.1002/wps.20614

The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials

2019

Conference Publication

Why do Australians with severe mental illness die 20 years prematurely? Answers from a retrospective nationwide cohort study of colorectal, cervical and prostate cancer screening

Kisely, S., Tuesley, K., Jordan, S., Kendall, B. and Siskind, D. (2019). Why do Australians with severe mental illness die 20 years prematurely? Answers from a retrospective nationwide cohort study of colorectal, cervical and prostate cancer screening. RANZCP 2019 Congress, Cairns, QLD Australia, 12–16 May 2019. London, United Kingdom: SAGE Publications. doi: 10.1177/0004867419836919

Why do Australians with severe mental illness die 20 years prematurely? Answers from a retrospective nationwide cohort study of colorectal, cervical and prostate cancer screening

2019

Conference Publication

What To Do When Clozapine Response Is Inadequate? Augmentation Strategies

Siskind, D., Lee, M., Ravindran, A., Zhang, Q., Ma, E., Motamarri, B. and Kisely, S. (2019). What To Do When Clozapine Response Is Inadequate? Augmentation Strategies. RANZCP 2019 Congress, Cairns, QLD Australia, 12–16 May 2019. London, United Kingdom: Sage Publications.

What To Do When Clozapine Response Is Inadequate? Augmentation Strategies

2019

Conference Publication

What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia

Parker, S., Hopkins, G., Siskind, D., Harris, M., McKeon, G. and Dark, F. (2019). What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia. RANZCP Congress, Cairns, QLD Australia, 12-16 May 2019. London, United Kingdom: Sage Publications.

What Have We Learnt From More Than 20 Years of Clinically Operated Community-Based Residential Rehabilitation For Severe Mental Illness in Australia

2019

Conference Publication

Integration of Research Into Psychiatric Practice: A Guide for New Investigators and the Scholarly Project

Siskind, D., Lawn, S., Kisely, S., Warren, N., O'Donoghue, B. and Harris, A. (2019). Integration of Research Into Psychiatric Practice: A Guide for New Investigators and the Scholarly Project. RANZCP 2019 Congress, Cairns, QLD Australia, 12–16 May 2019. London, United Kingdom: Sage Publications.

Integration of Research Into Psychiatric Practice: A Guide for New Investigators and the Scholarly Project

2019

Conference Publication

A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders

Suetani, S., Chapman, J., Korman, N., Chapman, C., Dark, F., Dodd, C., Parker, S. and Siskind, D. (2019). A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders. RANZCP 2019 Congress, Cairns, Australia, 12–16 May 2019. London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919

A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders

2019

Conference Publication

Quality and safe use of clozapine: a practioner's guide

O'Donaghue, B., Clark, S., Every-Palmer, S. and Siskind, D. (2019). Quality and safe use of clozapine: a practioner's guide. RANZCP 2019 Congress, Cairns, Australia, 12–16 May 2019. London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919

Quality and safe use of clozapine: a practioner's guide

2019

Conference Publication

Effects of high intensity interval training in people with severe mental illness: a systematic review of intervention studies - considering diverse approaches to improving mental and physical health outcomes

Korman, N., Chapman, J. J., Firth, J., Armour, M., Suetani, S., Rosenbaum, S., Vancampfort, D., Stubbs, B. and Siskind, D. (2019). Effects of high intensity interval training in people with severe mental illness: a systematic review of intervention studies - considering diverse approaches to improving mental and physical health outcomes. RANZCP 2019 Congress, Cairns, Australia, 12-16 May 2019 . London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919 Article information Full Access

Effects of high intensity interval training in people with severe mental illness: a systematic review of intervention studies - considering diverse approaches to improving mental and physical health outcomes

2019

Conference Publication

Safety and use of E-cigarettes as a harm minimization measure - What's the evidence?

Kisely, S., Arroyo, D. and Siskind, D. (2019). Safety and use of E-cigarettes as a harm minimization measure - What's the evidence?. RANZCP 2019 Congress, Cairns, QLD Australia, 12–16 May 2019. London, United Kingdom: Sage Publications. doi: 10.1177/0004867419836919

Safety and use of E-cigarettes as a harm minimization measure - What's the evidence?

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au